Literature DB >> 8145734

Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.

B S Whaley1, N Yuan, L Birnbaumer, R B Clark, R Barber.   

Abstract

The effect of varying levels of beta 2-adrenergic receptor (beta AR) expression on the capacity of the receptor to activate adenylyl cyclase through regulatory G proteins has been systematically explored in this paper, using differential expression of hamster and human beta AR in L cells. Equations have been developed based on the cycle of G protein activation first proposed by Cassel and Selinger and the mobile receptor model, which assumes that hormone-bound beta AR can stimulate a number of different adenylyl cyclase moieties through the G protein during a single cycle of activation. These equations predict the relationship of receptor number to the EC50 (potency) and Vmax (efficacy) for adenylyl cyclase activation. L cell clones were selected with stable expression of the beta AR over a 2000-fold range of levels (from 5 to 10,000 fmol/mg of membrane protein). Experimentally determined values for the EC50 and the Vmax for epinephrine stimulation of adenylyl cyclase over the entire range of receptor levels were found to be in excellent agreement with predictions of the traditionally accepted models. A method is introduced that allows calculation of beta AR coupling efficiency while taking into account the effect of variable receptor levels. The approach provides a quantitative means for the determination of coupling efficiency of the receptor/G protein/adenylyl cyclase system over wide variations in receptor levels and allows for a rational comparison of coupling efficiencies of wild-type and mutant receptors when receptor levels differ.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145734

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

1.  Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.

Authors:  J Mialet; I Berque-Bestel; P Eftekhari; M Gastineau; M Giner; Y Dahmoune; P Donzeau-Gouge; J Hoebeke; M Langlois; S Sicsic; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

3.  Constitutive somatostatin receptor activity determines tonic pituitary cell response.

Authors:  Anat Ben-Shlomo; Cuiqi Zhou; Oxana Pichurin; Vera Chesnokova; Ning-Ai Liu; Michael D Culler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-01-08

4.  Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.

Authors:  Luis E Gimenez; Faiza Baameur; Sharat J Vayttaden; Richard B Clark
Journal:  Mol Pharmacol       Date:  2015-03-17       Impact factor: 4.436

5.  Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Lee-Yuan Liu-Chen
Journal:  Biochem Pharmacol       Date:  2006-11-03       Impact factor: 5.858

6.  Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes.

Authors:  S R Post; R Hilal-Dandan; K Urasawa; L L Brunton; P A Insel
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

7.  Variable Dependence of Signaling Output on Agonist Occupancy of Ste2p, a G Protein-coupled Receptor in Yeast.

Authors:  Rajashri Sridharan; Sara M Connelly; Fred Naider; Mark E Dumont
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

8.  Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Ellen M Unterwald; Lee-Yuan Liu-Chen
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

9.  Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.

Authors:  Wenkuan Xin; Tuan M Tran; Wito Richter; Richard B Clark; Thomas C Rich
Journal:  J Gen Physiol       Date:  2008-03-17       Impact factor: 4.086

10.  Quantitative modeling of GRK-mediated beta2AR regulation.

Authors:  Sharat J Vayttaden; Jacqueline Friedman; Tuan M Tran; Thomas C Rich; Carmen W Dessauer; Richard B Clark
Journal:  PLoS Comput Biol       Date:  2010-01-22       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.